Understanding the characteristics and risks of HFRS patients
A Retrospective Cohort Study of Hemorrhagic Fever With Renal Syndrome
This study looks at the health details and risks of people with Haemorrhagic Fever with Renal Syndrome (HFRS) to help improve prevention and treatment strategies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tongji Hospital Academic / other |
| Locations | 8 sites (Guangshui, Hu Bei Province and 7 other locations) |
| Trial ID | NCT06020326 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the clinical characteristics of patients diagnosed with Haemorrhagic Fever with Renal Syndrome (HFRS) by collecting data from multiple hospitals. It will explore various risk factors associated with the occurrence and mortality of HFRS, utilizing a retrospective cohort design. The study will gather comprehensive information including demographics, clinical manifestations, laboratory results, and treatment outcomes to develop a risk prediction model for HFRS. This approach seeks to enhance prevention and treatment strategies for this significant public health issue in China.
Who should consider this trial
Good fit: Ideal candidates for this study are inpatients who have been clinically diagnosed with Haemorrhagic Fever with Renal Syndrome.
Not a fit: Patients with previous chronic kidney disease or those who are pregnant or perinatal will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and management strategies for patients with HFRS.
How similar studies have performed: While there may be limited studies specifically on HFRS, similar retrospective cohort studies have shown success in identifying risk factors and improving patient outcomes in other infectious diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The patients must meet all of the following criteria: * Inpatient with clinical diagnosis of Haemorrhagic Fever with Renal Syndrome Exclusion Criteria: Exclude patients who meet any of the following criteria: * Patients with previous chronic kidney disease * Pregnant or perinatal patients * Patients unsuitable for inclusion by investigators' evaluation
Where this trial is running
Guangshui, Hu Bei Province and 7 other locations
- No.1 Peoples Hospital of Guangshui — Guangshui, Hu Bei Province, China (Recruiting)
- Huanggang Central Hospital — Huanggang, Hu Bei Province, China (Recruiting)
- People's Hospital of Luotian County — Huanggang, Hu Bei Province, China (Recruiting)
- People's Hospital of Macheng City, Affiliated Hospital of Hubei University of Science and Technology — Macheng, Hu Bei Province, China (Recruiting)
- Qianjiang Central Hospital — Qianjiang, Hu Bei Province, China (Recruiting)
- Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology — Wuhan, Hu Bei Province, China (Recruiting)
- Xianning Central Hospital — Xianning, Hu Bei Province, China (Recruiting)
- The Third Peoples Hospital of Yichang — Yichang, Hu Bei Province, China (Recruiting)
Study contacts
- Principal investigator: Qin Ning, Professor — Tongji Hospital
- Study coordinator: Qin Ning, Professor
- Email: qning@vip.sina.com
- Phone: +8613971521450
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.